XILIO THERAPEUTICS INC
Q3 2026 13F Holders
Symbol
XLO
CUSIP
98422T209
Type
Equity
Class
COM
Num filers
3
Total reported value, excl. options
$376k
Compare 2026 Q3 to
2026 Q2
2026 Q1
Manager
Report Date
Value ($000)
Shares
Option Type